Navigation Links
MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
Date:10/10/2007

rmaceutical company committed to the development of new drug candidates and whose current drug candidates include:

-- MCT-125 for the treatment of primary fatigue in MS patients.

-- MCT-175 for the treatment of relapsing-remitting MS.

-- MCT-465 for the treatment of TLR3 positive breast cancers.

-- MCT-475 for the treatment of TLR3 positive cervical cancers.

For more information about MultiCell Technologies, please visit http://www.multicelltech.com

Caution Regarding Forward-Looking Statements

Any statements in this press release about MultiCell's expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the "Act"). These statements are often, but not always, made through the use of words or phrases such as "believe," "will," "expect," "anticipate," "estimate," "intend," "plan," "forecast," "could," and "would." Examples of such forward looking statements include statements regarding the timing, design, scope, and anticipated results of our clinical development of MCT-125, statements regarding selling, using or developing the FA2N-4 cell line and MultiCell's identification of new drug targets. MultiCell bases these forward-looking statements on current expectations about future events. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by any forward-looking statement. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or projections in the forward-looking statement include, but are not limited to, the risk that we might not achieve our anticipated clinical development milestones, receive regulatory
'/>"/>

SOURCE MultiCell Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Barriers will not stop convergence of medical technologies
2. Merge Technologies net loss doubles to $10.1M
3. Making deals with evolving technologies in mind
4. Third Wave Technologies to raise $14.9M through private debt
5. Meier joins Broadlook Technologies as COO
6. Platypus Technologies secures $450K SBIR grant
7. Napier joins board of Third Wave Technologies
8. aOva Technologies raises $3 million
9. Consumer, business technologies face same challenges
10. Promega to get early access to WARF technologies under new agreement
11. Linda Weber to run Fiservs Interactive Technologies unit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015 /PRNewswire/ - The Fight Against Cancer ... to announce the formation of Turnstone Biologics Inc. ... for cancer that harness the patient,s own immune ... collaboration between the Children,s Hospital of ... University, the Ontario Institute for Cancer Research (OICR), ...
(Date:5/4/2015)... -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a ... needs in the areas of inflammation, oncology and biodefense, ... from three of its biodefense programs at the upcoming ... May 12-14, 2015 to be held at the America,s ... St. Louis MO 63101. The ...
(Date:5/4/2015)... GERMANTOWN, Md. , May 4, 2015   ... it will release first quarter 2015 financial results after ... will host a conference call that day at 5:30 ... general business update. The conference call may ... (International) and asking to join the "Intrexon Conference Call."  ...
(Date:5/1/2015)... 2015 OncoTAb, Inc., a ... company, announced that Pinku Mukherjee, Ph.D. has received the ... of Governors’ highest faculty honor. Mukherjee received the award, ... for her innovative research and development of cancer diagnostics ... a crowning moment in my scientific career,” said Mukherjee, ...
Breaking Biology Technology:Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies 2Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies 3Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 2Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 3Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 4Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 5Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 6Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 7Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 8Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 9Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 10Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 11Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 12Intrexon to Announce First Quarter 2015 Financial Results on Monday, May 11, 2015 2OncoTAb CSO Awarded the University of North Carolina’s O. Max Gardner Award 2
... , Research Superiority Award to ... Texas Center for Superconductivity (TcSUH-ARH) , HOUSTON , ... received a Research Superiority Award from the Texas Emerging Technology Fund ... of the ETF board. The University of Houston ,s Texas ...
... , WASHINGTON , Feb. 3 The Advisory ... W. Musslewhite , Chief Executive Officer, and Michael T. Kirshbaum ... investor conferences. , Mr. Musslewhite and Mr. Kirshbaum are scheduled to ... PM EST at the UBS 20th Annual Global Healthcare Services ...
... ... low cost label and barcode printing for RURO lab management software. , ... (PRWEB) February 3, 2010 -- ... the newly available Brady BBP™11 Label Printer, a compact, budget friendly thermal label printer ...
Cached Biology Technology:UH Superconductivity Center Receives Texas Emerging Technology Fund Award 2UH Superconductivity Center Receives Texas Emerging Technology Fund Award 3UH Superconductivity Center Receives Texas Emerging Technology Fund Award 4UH Superconductivity Center Receives Texas Emerging Technology Fund Award 5UH Superconductivity Center Receives Texas Emerging Technology Fund Award 6UH Superconductivity Center Receives Texas Emerging Technology Fund Award 7The Advisory Board Company to Present at Upcoming Conferences 2RURO and Brady Team to Deliver Solutions for Mid-market Laboratory Applications 2RURO and Brady Team to Deliver Solutions for Mid-market Laboratory Applications 3
(Date:4/2/2015)... 2015 In the current ... outperforms the strongest competitors, showing outstanding performance in ... system is capable of a throughput of 5.000.000 ... to be ten times faster than most competitors ...      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ) ...
(Date:4/1/2015)... --  Medisafe ™, the leading global medication management platform ... and Android smartphones and tablets, announces today ... to allow patients to track and correlate their adherence ... will be able to visualize in real-time how taking ... as glucose levels and blood pressure. "Patients ...
(Date:3/24/2015)... , Mar. 24, 2015 Research and Markets ... the "Global Iris Recognition Market 2015-2019" report ... Global Iris Recognition market to grow at a CAGR ... This report covers the present scenario and the growth ... period 2015-2019. To calculate the market size, the report ...
Breaking Biology News(10 mins):DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
... in Spanish . , New World hemorrhagic ... that can cause terrible, Ebola-like symptoms. Current treatments are ... Hughes Medical Institute (HHMI) researchers have discovered exactly how ... onto and infects human cells, offering a much-needed lead ...
... built a sensor array that, for the first time, can ... living cell. Hydrogen peroxide has long been known to ... evidence that points to a more beneficial role: it appears ... pathway that stimulates growth, among other functions. When that ...
... better prevent diseases may be in our future, just ... University recently published an academic journal article discussing the ... of food on gene expression. The researchers discussed the ... from expressing disease. The researchers said nutrigenomics could completely ...
Cached Biology News:New ways to disarm deadly South American hemorrhagic fever viruses 2New ways to disarm deadly South American hemorrhagic fever viruses 3New sensor array detects single molecules for the first time 2Studies on nutrients, gene expression could lead to tailored diets for disease prevention 2Studies on nutrients, gene expression could lead to tailored diets for disease prevention 3
CASPR (H-66)...
Homo sapiens toll interacting protein Antigen: Recombinant Protein...
Human SIGIRR MAb (Clone 162201)...
... EPS 1001 Power Supply, 1. 1000 ... voltage, constant current, and constant power ... for precision and reproducibility.Stores and recalls ... flatbed gels on Multiphor II ...
Biology Products: